April 18, 2024
RegMed Investors’ (RMi) pre-open: the down draft doesn’t seem to be over
April 17, 2024
RegMed Investors’ (RMi) pre-open: Start BUYING-in after a 5-session downhill slide
April 16, 2024
RegMed Investors’ (RMi) pre-open: who knows where share pricing goes as the sword of Damocles hangs overhead
April 15, 2024
RegMed Investors’ (RMi) pre-open: Any which way you can
April 12, 2024
RegMed Investors’ (RMi) pre-open: don’t
April 11, 2024
RegMed Investors’ (RMi) pre-open: a double whammy of market and sector arithmetic
April 10, 2024
RegMed Investors’ (RMi) pre-open: another little progress against inflation report?
April 9, 2024
RegMed Investors’ (RMi) pre-open: WHAT and WHEN are the catalysts to move share pricing
April 8, 2024
RegMed Investors’ (RMi) pre-open: expectation versus circumstances
April 5, 2024
RegMed Investors’ (RMi) pre-open: The sector remains highly sensitive in any indication
April 4, 2024
RegMed Investors’ (RMi) pre-open: missing the beat or beating the miss?
April 3, 2024
RegMed Investors’ (RMi) pre-open: economic and other gene editing therapy company headwinds riled the sector
April 2, 2024
RegMed Investors’ (RMi) pre-open: after a dip and Monday’s trip, caution
April 1, 2024
RegMed Investors’ (RMi) pre-open: Steaming into April, risk still flows through the sector and market
March 29, 2024
RegMed Investors’ (RMi) pre-open: Personal Consumption Expenditures price index (PCE) rose
March 28, 2024
RegMed Investors’ (RMi) pre-open: Occam’s Razor
March 27, 2024
RegMed Investors’ (RMi) pre-open: climbing a wall of worry
March 26, 2024
RegMed Investors’ (RMi) pre-open: get some or none
March 25, 2024
RegMed Investors’ (RMi) pre-open: end of March and Q1/24 this week
March 22, 2024
RegMed Investors’ (RMi) pre-open: Buy or fly, trade or fade?
March 21, 2024
RegMed Investors’ (RMi) pre-open: Not for nothing
March 20, 2024
RegMed Investors’ (RMi) pre-open: caution
March 19, 2024
RegMed Investors’ (RMi) pre-open: riding the wave
March 18, 2024
RegMed Investors’ (RMi) pre-open: which way to safety?
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors